- Home
- ETW vs CDMO Comparison
ETW vs CDMO Comparison
Compare ETW & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETW
- CDMO
- Stock Information
- Founded
- ETW 2005
- CDMO 1981
- Country
- ETW United States
- CDMO United States
- Employees
- ETW N/A
- CDMO N/A
- Industry
- ETW Investment Managers
- CDMO Biotechnology: Pharmaceutical Preparations
- Sector
- ETW Finance
- CDMO Health Care
- Exchange
- ETW Nasdaq
- CDMO Nasdaq
- Market Cap
- ETW N/A
- CDMO 793.8M
- IPO Year
- ETW N/A
- CDMO N/A
- Fundamental
- Price
- ETW $8.54
- CDMO $12.50
- Analyst Decision
- ETW
- CDMO Hold
- Analyst Count
- ETW 0
- CDMO 3
- Target Price
- ETW N/A
- CDMO $12.25
- AVG Volume (30 Days)
- ETW 284.6K
- CDMO 1.3M
- Earning Date
- ETW 01-01-0001
- CDMO 12-10-2024
- Dividend Yield
- ETW 8.61%
- CDMO N/A
- EPS Growth
- ETW N/A
- CDMO N/A
- EPS
- ETW N/A
- CDMO N/A
- Revenue
- ETW N/A
- CDMO $150,445,000.00
- Revenue This Year
- ETW N/A
- CDMO $19.04
- Revenue Next Year
- ETW N/A
- CDMO $20.87
- P/E Ratio
- ETW N/A
- CDMO N/A
- Revenue Growth
- ETW N/A
- CDMO 6.75
- 52 Week Low
- ETW $6.96
- CDMO $5.90
- 52 Week High
- ETW $8.49
- CDMO $12.51
- Technical
- Relative Strength Index (RSI)
- ETW 51.04
- CDMO 65.47
- Support Level
- ETW $8.51
- CDMO $12.41
- Resistance Level
- ETW $8.67
- CDMO $12.50
- Average True Range (ATR)
- ETW 0.09
- CDMO 0.04
- MACD
- ETW 0.01
- CDMO -0.01
- Stochastic Oscillator
- ETW 57.58
- CDMO 84.62
About CDMO Avid Bioservices Inc.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.